Premium
Strides Pharma Science Ltd and the family office of its founder have set up a new company to mark their return to the injectables business, seven years after exiting the segment via a blockbuster deal with Mylan Inc. Strides said in a statement it will invest Rs 135 crore ($18.4 millon) ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
